These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17353644)

  • 21. [Irinotecan+cisplatin and irradiation are effective for brain metastases of gastric cancer--two case reports].
    Rino Y; Sekino Y; Yamada T; Nakayama T; Arai H; Kanari M; Saeki H; Yukawa N; Wada N; Masuda M; Higashida T; Imada T
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1095-8. PubMed ID: 17637547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Individualized chemotherapeutic regimen for each histological subtype of ovarian carcinoma.
    Shimizu Y
    Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():61-9. PubMed ID: 9210889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normal serum CA125 half-life and normal serum nadir CA125 level in patients with ovarian cancers.
    Yoshikawa T; Takano M; Kita T; Kudoh K; Sasaki N; Kato M; Watanabe A; Miyamoto M; Goto T; Furuya K
    Eur J Gynaecol Oncol; 2012; 33(3):269-73. PubMed ID: 22873097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination chemotherapy with paclitaxel and intraperitoneal cisplatin for ovarian cancer with disseminated lesions in the peritoneum and the diaphragm.
    Terauchi F; Moritake T; Yamamoto Y; Ogura H
    Int J Clin Oncol; 2002 Dec; 7(6):356-60. PubMed ID: 12494251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paclitaxel and cisplatin combination chemotherapy in recurrent epithelial ovarian cancer.
    Goldberg JM; Piver MS; Hempling RE; Recio FO
    Gynecol Oncol; 1996 Dec; 63(3):312-7. PubMed ID: 8946864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Second-line chemotherapy for recurrent ovarian cancer].
    Sugiyama T
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):28-32. PubMed ID: 15675578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of peritoneal dissemination of gastric cancer successfully treated by irinotecan combined with cisplatin].
    Masaki K; Nomura M; Inoue Y; Fujita S; Sakao J; Hirota M; Souda S
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):851-4. PubMed ID: 15984530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salvage weekly paclitaxel in recurrent ovarian cancer.
    Abu-Rustum NR; Aghajanian C; Barakat RR; Fennelly D; Shapiro F; Spriggs D
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-62-S15-67. PubMed ID: 9346225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cisplatin sensitivity of ovarian cancer in the histoculture drug response assay correlates to clinical response to combination chemotherapy with cisplatin, doxorubicin and cyclophosphamide.
    Ohie S; Udagawa Y; Kozu A; Komuro Y; Aoki D; Nozawa S; Moossa AR; Hoffman RM
    Anticancer Res; 2000; 20(3B):2049-54. PubMed ID: 10928150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of collagen gel droplet embedded culture drug sensitivity testing in ovarian cancer.
    Yabushita H; Ohnishi M; Komiyama M; Mori T; Noguchi M; Kishida T; Noguchi Y; Sawaguchi K; Noguchi M
    Oncol Rep; 2004 Aug; 12(2):307-11. PubMed ID: 15254694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of solitary metastatic splenic tumor of ovarian carcinoma].
    Kobayashi A; Yamaguchi M; Koarai N; Sugizaki N
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1341-5. PubMed ID: 9279357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of ovarian cancer in which a remarkable effect was seen with low-dose CDDP intratumoral injection of CPT-11].
    Inoue S; Kagawa M; Watanabe Y; Kusanishi H
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2336-8. PubMed ID: 12484068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial.
    Oza AM; Cibula D; Benzaquen AO; Poole C; Mathijssen RH; Sonke GS; Colombo N; Špaček J; Vuylsteke P; Hirte H; Mahner S; Plante M; Schmalfeldt B; Mackay H; Rowbottom J; Lowe ES; Dougherty B; Barrett JC; Friedlander M
    Lancet Oncol; 2015 Jan; 16(1):87-97. PubMed ID: 25481791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of a new anti-cancer drug regimen for surface epithelial-stromal ovarian cancer].
    Fushiki H; Hidaka T; Hori S; Fujimura M; Yamakawa Y; Izumi R
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):731-4. PubMed ID: 9571971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitoxantrone combined with paclitaxel as salvage therapy for platinum-refractory ovarian cancer: laboratory study and clinical pilot trial.
    Kurbacher CM; Bruckner HW; Cree IA; Kurbacher JA; Wilhelm L; Pöch G; Indefrei D; Mallmann P; Andreotti PE
    Clin Cancer Res; 1997 Sep; 3(9):1527-33. PubMed ID: 9815839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advanced ovarian cancer: phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel.
    Hoskins P; Vergote I; Cervantes A; Tu D; Stuart G; Zola P; Poveda A; Provencher D; Katsaros D; Ojeda B; Ghatage P; Grimshaw R; Casado A; Elit L; Mendiola C; Sugimoto A; D'Hondt V; Oza A; Germa JR; Roy M; Brotto L; Chen D; Eisenhauer EA
    J Natl Cancer Inst; 2010 Oct; 102(20):1547-56. PubMed ID: 20937992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose-escalated paclitaxel in 1-hour infusion with a fixed dose of cisplatin in previously untreated advanced ovarian cancer: a phase II trial of the Spanish Group for Ovarian Cancer.
    Cervantes A; Mendiola C; del Campo JM; Massuti B; Casado A; Escobedo A; Moyano A; Ojeda B; Poveda A; Benito D
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-40-S15-43. PubMed ID: 9346221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case of advanced gastric cancer with obstructive jaundice due to multiple liver metastasis successfully treated with the following combination therapy of CPT-11 and cisplatin after combination therapy of paclitaxel and TS-1].
    Watanabe T; Uchida M; Harada K; Homma N; Ogata N; Funada R; Hasegawa K; Soga K; Shibasaki K
    Gan To Kagaku Ryoho; 2007 Apr; 34(4):605-8. PubMed ID: 17431349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Second-line chemotherapy with low-dose CPT-11 and cisplatin for colorectal cancer resistant to 5-FU-based chemotherapy.
    Yoshimatsu K; Kato H; Ishibashi K; Hashimoto M; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Iwasaki K; Ogawa K
    Cancer Chemother Pharmacol; 2003 Dec; 52(6):465-8. PubMed ID: 12920569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical efficacy analysis of chemotherapy to lymph node metastasis in epithelial ovarian cancer].
    Wu LY; Zhang R; Huang MN; Li N; Wang GX; Liu LY
    Ai Zheng; 2003 Apr; 22(4):424-7. PubMed ID: 12704005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.